Aurobindo Pharma Nears Breakout Zone, Eyes ₹1,531 Target: SEBI RA WealthFino

Aurobindo Pharma is approaching a crucial technical point, which may lead to a breakout, according to SEBI-registered research firm WealthFino.

According to WealthFino's analysis, the stock consolidates through higher lows while challenging a trendline resistance level. 

At the time of writing, Aurobindo Pharma shares were trading at ₹1,182.60, down 1.79% or ₹21.50 on the day.

If the stock maintains its position above ₹1,225, backed by substantial volume, it will validate a bullish breakout that will propel the stock toward its target levels of ₹1,349, followed by ₹1,420, and possibly reaching ₹1,531.

WealthFino said the price above the 9-day exponential moving average (EMA) shows signs of short-term bullish momentum. 

The research firm pointed to the ₹1,145–₹1,155 range as an attractive area for additional purchases because buyers have historically shown interest in this zone.

According to WealthFino, the market will likely maintain its current sideways trend or pull back slightly unless the trendline breaks decisively. 

A fall below ₹1,098 shows market weakness, which might trigger additional price decreases.

On Stocktwits, retail sentiment was ‘bullish’ amid ‘normal’ message volume.

The stock has declined 12.6% so far in 2025.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Share

·

Add us on